Olympus Corp. (OCPNY) Rating Lowered to Strong Sell at Zacks Investment Research

Olympus Corp. (OTCMKTS:OCPNY) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a report released on Wednesday.

According to Zacks, “OLYMPUS CORPORATION is a Japan-based company. The Company is engaged in the manufacturing and selling of precision machineries and instruments. The businesses of the Company include Imaging System Business, Medical Systems Business, Life Science Business, Information and Communication Business, and Others Business. Olympus has always been a company that makes people’s dreams come true through innovative products. Olympus cameras have always been at the leading edge of innovation. “

Olympus Corp. (OCPNY) opened at 35.105 on Wednesday. Olympus Corp. has a 52-week low of $33.17 and a 52-week high of $39.49. The stock has a market capitalization of $12.01 billion, a P/E ratio of 16.320 and a beta of 1.11. The company’s 50-day moving average price is $34.47 and its 200 day moving average price is $36.35.

ILLEGAL ACTIVITY WARNING: “Olympus Corp. (OCPNY) Rating Lowered to Strong Sell at Zacks Investment Research” was originally posted by Stock Observer and is owned by of Stock Observer. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at https://www.thestockobserver.com/2017/10/13/olympus-corp-ocpny-rating-lowered-to-strong-sell-at-zacks-investment-research.html.

Olympus Corp. Company Profile

Olympus Corporation is engaged in the manufacture and sale of precision machineries and instruments. The Company’s segments include Medical Business, Scientific Solutions Business, Imaging Business and Others. The Company’s Medical Business manufactures and sells medical endoscopes, surgical endoscopes, endotherapy devices and other products.

Receive News & Ratings for Olympus Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply